• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于问卷的化脓性汗腺炎诊断:特定诊断问题的特异性、敏感性和阳性预测值。

Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.

机构信息

Department of Dermatology, Roskilde Hospital, Health Sciences Faculty, University of Copenhagen, DK-4000 Roskilde, Denmark.

出版信息

Br J Dermatol. 2010 Jul;163(1):102-6. doi: 10.1111/j.1365-2133.2010.09773.x. Epub 2010 Jan 17.

DOI:10.1111/j.1365-2133.2010.09773.x
PMID:20331444
Abstract

BACKGROUND

Estimates of the prevalence of hidradenitis suppurativa (HS) range from 0.33% to 4%. Further epidemiological data are therefore needed. Because of the hidden nature of the disease, physical screening may be cumbersome and questionnaire-based screening may be more appropriate.

OBJECTIVES

To establish the sensitivity (SE), specificity (SP) and positive predictive value (PPV) of simple diagnostic questions used in HS.

METHODS

Potential diagnostic questions regarding HS were identified and sent to 85 patients with HS and to an age- and sex-matched control group randomly selected among outpatients not being treated for HS. All respondents were recruited in the Department of Dermatology in Roskilde Hospital.

RESULTS

In total, 74 of 85 patients with HS (87%) returned the questionnaire (61 women and 13 men). Of these, 72 reported repeated outbreaks of painful nodules or boils in locations typical for HS compared with 13 patients in the control group. The SE ranged from 0.92 to 0.97, the SP from 0.82 to 0.86 and the PPV from 0.85 to 0.89. Boils appeared significantly more often in patients with HS, who also reported significantly greater suffering from their lesions.

CONCLUSIONS

The high diagnostic power suggests that all the questions are potentially useful. The clear symptomatology of HS may be a key factor. It is suggested that further improvement may be achieved by adding definitions of pimples, nodules or boils to future questionnaires. Similarly, adding the possibility to indicate uncommon locations, duration and quality-of-life impairment may benefit the diagnostic power.

摘要

背景

化脓性汗腺炎(HS)的患病率估计在 0.33%至 4%之间。因此,需要进一步的流行病学数据。由于该疾病的隐匿性,体格检查可能很繁琐,基于问卷的筛查可能更为合适。

目的

确定用于 HS 的简单诊断问题的敏感性(SE)、特异性(SP)和阳性预测值(PPV)。

方法

确定了有关 HS 的潜在诊断问题,并将其发送给 85 名 HS 患者和从未接受 HS 治疗的门诊患者中随机选择的年龄和性别匹配的对照组。所有受访者均在罗斯基勒医院皮肤科招募。

结果

共有 85 名 HS 患者中的 74 名(87%)返回了问卷(61 名女性和 13 名男性)。其中,72 名患者报告反复发作的疼痛结节或痈,位于 HS 的典型部位,而对照组只有 13 名患者。SE 范围为 0.92 至 0.97,SP 范围为 0.82 至 0.86,PPV 范围为 0.85 至 0.89。HS 患者的痈明显更为常见,且他们的皮损也明显更为痛苦。

结论

高诊断效能表明所有问题都具有潜在的用途。HS 的明显症状可能是一个关键因素。建议通过在未来的问卷中添加粉刺、结节或痈的定义,可能会进一步提高诊断效能。同样,添加不常见部位、持续时间和生活质量受损的可能性也可能会提高诊断效能。

相似文献

1
Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.基于问卷的化脓性汗腺炎诊断:特定诊断问题的特异性、敏感性和阳性预测值。
Br J Dermatol. 2010 Jul;163(1):102-6. doi: 10.1111/j.1365-2133.2010.09773.x. Epub 2010 Jan 17.
2
Interobserver variability of clinical scores in hidradenitis suppurativa is low.在化脓性汗腺炎中,临床评分的观察者间变异性较低。
Br J Dermatol. 2010 Jun;162(6):1261-8. doi: 10.1111/j.1365-2133.2010.09715.x. Epub 2010 Feb 22.
3
The influence of body weight on the prevalence and severity of hidradenitis suppurativa.体重对化脓性汗腺炎患病率及严重程度的影响。
Acta Derm Venereol. 2014 Sep;94(5):553-7. doi: 10.2340/00015555-1800.
4
[Prevalence of hidradenitis suppurativa in Denmark].[丹麦化脓性汗腺炎的患病率]
Ugeskr Laeger. 1998 Feb 2;160(6):847-9.
5
Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.化脓性汗腺炎患者的生活质量受损情况:一项61例病例的研究。
J Am Acad Dermatol. 2007 Apr;56(4):621-3. doi: 10.1016/j.jaad.2006.08.061. Epub 2006 Oct 20.
6
Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.化脓性汗腺炎(HS)在澳大利亚的流行情况、人口统计学特征和管理途径:一项基于人群的横断面研究。
PLoS One. 2018 Jul 24;13(7):e0200683. doi: 10.1371/journal.pone.0200683. eCollection 2018.
7
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.评估化脓性汗腺炎中反映吸烟和肥胖作用的客观指标。
Br J Dermatol. 2009 Oct;161(4):831-9. doi: 10.1111/j.1365-2133.2009.09198.x. Epub 2009 Apr 29.
8
Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): experience of a tertiary medical center.银屑病与化脓性汗腺炎(HS)共存的流行病学:一家三级医疗中心的经验
J Am Acad Dermatol. 2015 Oct;73(4):701-2. doi: 10.1016/j.jaad.2015.06.050.
9
Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment.口服异维A酸治疗化脓性汗腺炎无效:一项基于患者结局评估的回顾性研究
Dermatology. 2009;218(2):134-5. doi: 10.1159/000182261. Epub 2008 Dec 5.
10
Hidradenitis suppurativa: Epidemiology and scope of the problem.化脓性汗腺炎:流行病学和问题范围。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S4-7. doi: 10.1016/j.jaad.2015.07.052.

引用本文的文献

1
The polygenic architecture of hidradenitis suppurativa reveals signaling mechanisms that implicate epithelial remodeling.化脓性汗腺炎的多基因结构揭示了涉及上皮重塑的信号传导机制。
medRxiv. 2025 Jul 28:2025.07.25.25332168. doi: 10.1101/2025.07.25.25332168.
2
Prevalence of Hidradenitis Suppurativa among Healthy Adults in Abuja, Nigeria.尼日利亚阿布贾健康成年人中化脓性汗腺炎的患病率。
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539443.
3
Exploring Health Literacy among Adults with Hidradenitis Suppurativa.探究化脓性汗腺炎成年患者的健康素养
Dermatology. 2025;241(2):184-193. doi: 10.1159/000543286. Epub 2025 Jan 3.
4
Questionnaire-Based Global Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.基于问卷调查的化脓性汗腺炎全球患病率:一项系统评价和荟萃分析。
Dermatology. 2024 Dec 23:1-10. doi: 10.1159/000537920.
5
Comorbidities, Clinical Presentation, Subtypes, and Treatment of HS Patients in Lithuania.立陶宛HS患者的合并症、临床表现、亚型及治疗
J Clin Med. 2024 Jul 3;13(13):3900. doi: 10.3390/jcm13133900.
6
Hidradenitis Suppurativa Patient Referrals to a Canadian Community Dermatology Practice: A Retrospective Chart Review.化脓性汗腺炎患者转诊至加拿大社区皮肤科诊所:一项回顾性图表研究。
J Cutan Med Surg. 2024 Mar-Apr;28(2):136-140. doi: 10.1177/12034754231223451. Epub 2024 Jan 19.
7
Knowledge, attitudes, and perceptions of hidradenitis suppurativa among young adults in Singapore.新加坡年轻人对化脓性汗腺炎的认知、态度和看法。
JAAD Int. 2023 Apr 7;12:72-80. doi: 10.1016/j.jdin.2023.03.010. eCollection 2023 Sep.
8
New insights in hidradenitis suppurativa from a population-based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities.基于人群的荷兰队列研究对化脓性汗腺炎的新认识:患病率、吸烟行为、社会经济地位和合并症。
Br J Dermatol. 2022 May;186(5):814-822. doi: 10.1111/bjd.20954.
9
Hidradenitis Suppurativa: Where We Are and Where We Are Going.化脓性汗腺炎:现状与未来。
Cells. 2021 Aug 15;10(8):2094. doi: 10.3390/cells10082094.
10
Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24.《化脓性汗腺炎患者生活质量的评估:HSQoL-24 量表的验证》。
Acta Derm Venereol. 2021 Aug 25;101(8):adv00529. doi: 10.2340/00015555-3905.